Antibiotic-exposed patients with non-small-cell lung cancer preserve efficacy outcomes following first-line chemo-immunotherapy
Alessio Cortellini, Biagio Ricciuti, Francesco Facchinetti, Joao V. Alessi, Deepti Venkatraman, Filippo Gustavo Dall’Olio, Paola Cravero, Victor R. Vaz, Diego Ottaviani, Margarita Majem, A. Piedra, Ivana Sullivan, K.A. Lee, Giuseppe Lamberti, Nadiya Hussain, James J. Clark, Anita Bolina, Andrés Barba, José Carlos Benítez, Teresa Gorría, Laura Mezquita, Delphine Hoton, Frank Aboubakar Nana, Benjamin Besse, Mark M. Awad, David J. Pinato
Topics & Concepts
MedicineInternal medicineHazard ratioLung cancerImmunotherapyConfidence intervalGastroenterologyCancerOncologyCancer Immunotherapy and BiomarkersCancer Research and TreatmentsGut microbiota and health